サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/11/28 | 1,405 | 1,413 | 1,384 | 1,398 | +1 | +0.1% | 91,600 |
| 2016/11/25 | 1,415 | 1,415 | 1,381 | 1,397 | -19 | -1.3% | 142,900 |
| 2016/11/24 | 1,430 | 1,434 | 1,400 | 1,416 | +2 | +0.1% | 163,100 |
| 2016/11/22 | 1,400 | 1,426 | 1,360 | 1,414 | -2 | -0.1% | 411,000 |
| 2016/11/21 | 1,473 | 1,491 | 1,413 | 1,416 | -83 | -5.5% | 447,300 |
| 2016/11/18 | 1,525 | 1,533 | 1,487 | 1,499 | -19 | -1.3% | 221,100 |
| 2016/11/17 | 1,473 | 1,518 | 1,462 | 1,518 | +38 | +2.6% | 259,100 |
| 2016/11/16 | 1,458 | 1,485 | 1,448 | 1,480 | +11 | +0.7% | 196,200 |
| 2016/11/15 | 1,385 | 1,469 | 1,375 | 1,469 | +85 | +6.1% | 345,800 |
| 2016/11/14 | 1,377 | 1,408 | 1,372 | 1,384 | +9 | +0.7% | 90,400 |
| 2016/11/11 | 1,412 | 1,413 | 1,362 | 1,375 | -18 | -1.3% | 95,500 |
| 2016/11/10 | 1,367 | 1,420 | 1,362 | 1,393 | +86 | +6.6% | 235,700 |
| 2016/11/09 | 1,369 | 1,385 | 1,235 | 1,307 | -63 | -4.6% | 414,400 |
| 2016/11/08 | 1,400 | 1,403 | 1,357 | 1,370 | -25 | -1.8% | 107,500 |
| 2016/11/07 | 1,344 | 1,397 | 1,329 | 1,395 | +21 | +1.5% | 307,300 |
| 2016/11/04 | 1,310 | 1,378 | 1,301 | 1,374 | +38 | +2.8% | 297,900 |
| 2016/11/02 | 1,336 | 1,363 | 1,300 | 1,336 | -16 | -1.2% | 305,400 |
| 2016/11/01 | 1,399 | 1,402 | 1,348 | 1,352 | -57 | -4% | 327,100 |
| 2016/10/31 | 1,417 | 1,422 | 1,397 | 1,409 | -9 | -0.6% | 126,600 |
| 2016/10/28 | 1,444 | 1,461 | 1,394 | 1,418 | -22 | -1.5% | 173,300 |
| 2016/10/27 | 1,450 | 1,467 | 1,430 | 1,440 | +30 | +2.1% | 197,600 |
| 2016/10/26 | 1,392 | 1,423 | 1,392 | 1,410 | +11 | +0.8% | 106,500 |
| 2016/10/25 | 1,440 | 1,442 | 1,395 | 1,399 | -48 | -3.3% | 196,100 |
| 2016/10/24 | 1,473 | 1,489 | 1,436 | 1,447 | -33 | -2.2% | 110,700 |
| 2016/10/21 | 1,449 | 1,492 | 1,441 | 1,480 | +46 | +3.2% | 287,500 |
| 2016/10/20 | 1,425 | 1,438 | 1,416 | 1,434 | +9 | +0.6% | 81,900 |
| 2016/10/19 | 1,415 | 1,442 | 1,412 | 1,425 | -1 | -0.1% | 74,300 |
| 2016/10/18 | 1,407 | 1,436 | 1,405 | 1,426 | +19 | +1.4% | 124,100 |
| 2016/10/17 | 1,416 | 1,430 | 1,402 | 1,407 | -20 | -1.4% | 85,700 |
| 2016/10/14 | 1,429 | 1,444 | 1,405 | 1,427 | +10 | +0.7% | 130,100 |
| 2016/10/13 | 1,429 | 1,433 | 1,404 | 1,417 | -1 | -0.1% | 84,500 |
| 2016/10/12 | 1,465 | 1,466 | 1,390 | 1,418 | -34 | -2.3% | 194,300 |
| 2016/10/11 | 1,465 | 1,502 | 1,443 | 1,452 | -4 | -0.3% | 186,900 |
| 2016/10/07 | 1,434 | 1,461 | 1,424 | 1,456 | +17 | +1.2% | 132,900 |
| 2016/10/06 | 1,457 | 1,466 | 1,435 | 1,439 | -27 | -1.8% | 120,900 |
| 2016/10/05 | 1,438 | 1,470 | 1,430 | 1,466 | +26 | +1.8% | 160,500 |
| 2016/10/04 | 1,512 | 1,520 | 1,435 | 1,440 | -68 | -4.5% | 305,800 |
| 2016/10/03 | 1,502 | 1,540 | 1,491 | 1,508 | +18 | +1.2% | 200,800 |
| 2016/09/30 | 1,501 | 1,510 | 1,470 | 1,490 | -45 | -2.9% | 283,400 |
| 2016/09/29 | 1,580 | 1,580 | 1,515 | 1,535 | -45 | -2.8% | 272,800 |
| 2016/09/28 | 1,577 | 1,585 | 1,550 | 1,580 | -5 | -0.3% | 231,200 |
| 2016/09/27 | 1,589 | 1,601 | 1,465 | 1,585 | -10 | -0.6% | 768,500 |
| 2016/09/26 | 1,487 | 1,610 | 1,480 | 1,595 | +108 | +7.3% | 830,400 |
| 2016/09/23 | 1,452 | 1,502 | 1,419 | 1,487 | +120 | +8.8% | 716,500 |
| 2016/09/21 | 1,361 | 1,372 | 1,346 | 1,367 | +25 | +1.9% | 102,400 |
| 2016/09/20 | 1,379 | 1,399 | 1,341 | 1,342 | -30 | -2.2% | 179,500 |
| 2016/09/16 | 1,337 | 1,372 | 1,319 | 1,372 | +50 | +3.8% | 137,500 |
| 2016/09/15 | 1,315 | 1,357 | 1,303 | 1,322 | -14 | -1% | 168,100 |
| 2016/09/14 | 1,380 | 1,380 | 1,328 | 1,336 | -69 | -4.9% | 271,100 |
| 2016/09/13 | 1,378 | 1,409 | 1,361 | 1,405 | +41 | +3% | 217,500 |
2101～
2150
件表示中 / 2501件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 219,100円 | - | - | 0.00% | - | 101.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 377,700円 | -6.4% | -71.8% | 5.03% | 42.19倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 310,500円 | +21.7% | +999.9% | 0.00% | 13.01倍 | 4.31倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 293,100円 | +7.9% | -3.3% | 2.73% | 8.15倍 | 0.84倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
